Canal Insurance Co’s Abbott Laboratories Position
Does Canal Insurance Co own Abbott Laboratories (ABT)? Yes — 90.0K shares worth $9M (+1.99% of its 13F portfolio) as of Q1 2026, up from 40.0K shares the prior filed quarter.
Position Value
$9M
Q1 2026
Shares
90.0K
% of Portfolio
+1.99%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 90.0K | $9M | +1.99% |
| Q4 2025 | 40.0K | $5M | +1.21% |
| Q3 2025 | 40.0K | $5M | +1.14% |
| Q2 2025 | 40.0K | $5M | +1.22% |
| Q1 2025 | 40.0K | $5M | +1.25% |
| Q4 2024 | 40.0K | $5M | +1.17% |
| Q3 2024 | 40.0K | $5M | +1.06% |
| Q2 2024 | 40.0K | $4M | +1.10% |
| Q1 2024 | 40.0K | $5M | +1.16% |
| Q4 2023 | 40.0K | $4M | +1.22% |
| Q3 2023 | 40.0K | $4M | +1.11% |
| Q2 2023 | 40.0K | $4M | +1.22% |
| Q1 2023 | 40.0K | $4M | +1.10% |
| Q4 2022 | 40.0K | $4M | +1.20% |
| Q3 2022 | 40.0K | $4M | +1.15% |
| Q2 2022 | 40.0K | $4M | +1.26% |
| Q1 2022 | 40.0K | $5M | +1.30% |
| Q4 2021 | 40.0K | $6M | +1.65% |
| Q3 2021 | 50.0K | $6M | +2.01% |
| Q2 2021 | 50.0K | $6M | +2.04% |
| Q1 2021 | 40.0K | $5M | +1.83% |
| Q4 2020 | 40.0K | $4M | +1.83% |
| Q3 2020 | 40.0K | $4M | +1.75% |
| Q2 2020 | 40.0K | $4M | +1.44% |
| Q1 2020 | 40.0K | $3M | +1.22% |
| Q4 2019 | 40.0K | $3M | +1.24% |
| Q3 2019 | 40.0K | $3M | +1.18% |
| Q2 2019 | 40.0K | $3M | +1.11% |
| Q1 2019 | 40.0K | $3M | +1.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Canal Insurance Co’s full portfolio or all institutional holders of ABT.